PMA P030004

Device
Onyx™ Liquid Embolic System (LES)
Applicant
Ev3 Neurovascular
PMA number
P030004
Supplement
S029
Product code
SGU
Decision date
2026-08-05
Generic name
Neurovascular Liquid Embolic Agent
Approval order statement
Approval to add the Onyx 12 LES to the Onyx LES product line for embolization of the middle meningeal artery (MMA) as an adjunct to surgery for the treatment of symptomatic subacute or chronic subdural hematoma (SDH).

Current openFDA PMA Record#

Device
Onyx™ Liquid Embolic System (LES)
Applicant
Ev3 Neurovascular
PMA number
P030004
Supplement
S042
Product code
SGU
Generic name
Neurovascular Liquid Embolic Agent
Decision date
2026-08-05
Decision code
APPR
Date received
2026-03-20
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Approval order statement
Approval to add the Onyx 12 LES to the Onyx LES product line for embolization of the middle meningeal artery (MMA) as an adjunct to surgery for the treatment of symptomatic subacute or chronic subdural hematoma (SDH).